Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy C4 Therapeutics stock | 26.1
Own C4 Therapeutics stock in just a few minutes.
C4 Therapeutics, Inc. is an other business based in the US. C4 Therapeutics shares (CCCC) are listed on the NASDAQ and all prices are listed in US Dollars. C4 Therapeutics employs 88 staff and has a trailing 12-month revenue of around USD$30.1 million.
How to buy shares in C4 Therapeutics
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for C4 Therapeutics. Find the stock by name or ticker symbol: CCCC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until C4 Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$26.1, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of C4 Therapeutics, depending on your broker.
- Check in on your investment. Congratulations, you own a part of C4 Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
C4 Therapeutics share price
Use our graph to track the performance of CCCC stocks over time.C4 Therapeutics shares at a glance
Information last updated 2020-10-18.
| Latest market close | USD$26.1 |
|---|---|
| 52-week range | USD$19 - USD$28.75 |
| 50-day moving average | USD$24.6809 |
| 200-day moving average | USD$24.6809 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Compare trading platforms
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy C4 Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
C4 Therapeutics price performance over time
Historical closes compared with the close of $26.1 from 2020-10-19
| 1 week (2020-10-15) | 3.12% |
|---|---|
| 1 month (2020-09-18) | N/A |
| 3 months (2020-07-18) | N/A |
| 6 months (2020-04-18) | N/A |
| 1 year (2019-10-18) | N/A |
|---|---|
| 2 years (2018-10-18) | N/A |
| 3 years (2017-10-18) | N/A |
| 5 years (2015-10-18) | N/A |
C4 Therapeutics financials
| Revenue TTM | USD$30.1 million |
|---|---|
| Gross profit TTM | USD$21.4 million |
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | -142.46% |
| Book value | N/A |
| Market capitalisation | USD$1 billion |
TTM: trailing 12 months
C4 Therapeutics share dividends
We're not expecting C4 Therapeutics to pay a dividend over the next 12 months.
C4 Therapeutics overview
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma, peripheral T-cell lymphoma, and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid malignancies; and BRAF V600E and RET programs for genetically defined resistant solid tumors. It has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. C4 Therapeutics, Inc. was founded in 2015 and is headquartered in Watertown, Massachusetts.
Frequently asked questions
More guides on finder
-
How to buy M/I Homes stock | 46.49
Steps to owning and managing MHO, with 24-hour and historical pricing before you buy.
-
How to buy Harmonic stock | 6.35
Steps to owning and managing HLIT, with 24-hour and historical pricing before you buy.
-
How to buy Exela Technologies stock | 0.45
Steps to owning and managing XELA, with 24-hour and historical pricing before you buy.
-
How to buy Pinduoduo stock | 89.07
Steps to owning and managing PDD, with 24-hour and historical pricing before you buy.
-
How to buy JAKKS Pacific stock | 4.23
Steps to owning and managing JAKK, with 24-hour and historical pricing before you buy.
-
How to buy Immunomedics stock | 87.72
Steps to owning and managing IMMU, with 24-hour and historical pricing before you buy.
-
How to buy Perceptron stock | 6.88
Steps to owning and managing PRCP, with 24-hour and historical pricing before you buy.
-
How to buy Monro stock | 43
Steps to owning and managing MNRO, with 24-hour and historical pricing before you buy.
-
How to buy Amneal Pharmaceuticals stock | 5.21
Steps to owning and managing AMRX, with 24-hour and historical pricing before you buy.
-
How to buy Yum! Brands stock | 98.53
Steps to owning and managing YUM, with 24-hour and historical pricing before you buy.
Ask an Expert